NCT06729619View on ClinicalTrials.gov

Concentration Monitoring of Anti-infective Drugs in Human Cerebrospinal Fluid and Its Clinical Application

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 3, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Intracranial InfectionCentral Infection
Interventions
DRUG

The concentration of anti-infective drugs in blood and cerebrospinal fluid will be determined.

Blood and cerebrospinal fluid concentrations of anti-infective drugs such as vancomycin, meropenem, linezolid, cefoperazone sulbactam and ceftazidime ababactam will be monitored after the drug reaches a steady state.

Trial Locations (1)

250014

Shandong Provincial Qianfoshan Hospital, Jinan

All Listed Sponsors
lead

Xueyan Cui

OTHER

NCT06729619 - Concentration Monitoring of Anti-infective Drugs in Human Cerebrospinal Fluid and Its Clinical Application | Biotech Hunter | Biotech Hunter